Use of Corticosteroids and Corticosteroid-Sparing Agents in the Initial Management of Idiopathic Pulmonary Fibrosis

Oct-08

AUTHORS : Dr Jeffrey C. Munson (Details for study: University of Pennsylvania), Geisel School of Medicine, Dartmouth/The Dartmouth Institute, Geisel School of Medicine/Dartmouth-Hitchcock Medical Center, 1 Medical Center Drive, Lebanon, New Hampshire 03756, USA – Email: Jeffrey.C.Munson@Dartmouth.edu – Profile: https://www.dartmouth-hitchcock.org/findaprovider/provider/1126/Jeffrey-C-Munson

JOURNAL : Chest

REFERENCE: 134(4)(S2):20S

DOI : 10.1378/chest.134.4_MeetingAbstracts.s20002

Use of Corticosteroids and Corticosteroid-Sparing Agents in the Initial Management of Idiopathic Pulmonary Fibrosis

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement